These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8681558)

  • 41. Hypersensitivity reactions to drugs in acquired immunodeficiency syndrome.
    Ackerman Z; Levy M
    Postgrad Med J; 1987 Jan; 63(735):55-6. PubMed ID: 2890152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fixed eruption due to erythromycin. A case report.
    Florido Lopez JF; Lopez Serrano MC; Belchi Hernandez J; Estrada Rodriguez JL
    Allergy; 1991 Jan; 46(1):77-8. PubMed ID: 1826819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Escitalopram, labial pigmentation and lichenoid eruption].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008 Apr; 135(4):346. PubMed ID: 18420093
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.
    Rosenbaum J; Alex G; Roberts H; Orchard D
    J Paediatr Child Health; 2010 Apr; 46(4):193-6. PubMed ID: 20546480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fixed drug eruption due to ciprofloxacin.
    Dhar S; Sharma VK
    Br J Dermatol; 1996 Jan; 134(1):156-8. PubMed ID: 8745905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fixed drug eruption due to fluconazole.
    Heikkilä H; Timonen K; Stubb S
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):883-4. PubMed ID: 10767695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fixed drug eruptions. Incidence, recognition, and avoidance.
    Lee AY
    Am J Clin Dermatol; 2000; 1(5):277-85. PubMed ID: 11702319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sargramostim for sulfasalazine-induced agranulocytosis.
    Rospond RM; Glowacki RC; Mailliard JA
    Clin Pharm; 1993 Mar; 12(3):179. PubMed ID: 8098278
    [No Abstract]   [Full Text] [Related]  

  • 49. Fixed drug eruption from clarithromycin.
    Rosina P; Chieregato C; Schena D
    Contact Dermatitis; 1998 Feb; 38(2):105. PubMed ID: 9506224
    [No Abstract]   [Full Text] [Related]  

  • 50. A case of severe reversible lung disease caused by sulphasalazine.
    Manchanda S; Rees PJ
    Int J Clin Pract; 1999; 53(3):233-5. PubMed ID: 10665141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fixed drug eruption on the penis due to oxcarbazepine.
    Schuster C; Kränke B; Aberer W; Komericki P
    Arch Dermatol; 2011 Mar; 147(3):362-4. PubMed ID: 21422354
    [No Abstract]   [Full Text] [Related]  

  • 52. [Case of fixed drug eruption due to allylisopropylacetylurea].
    Wakisaka C; Iitoyo M
    Arerugi; 2005 Jun; 54(6):569-71. PubMed ID: 16156502
    [No Abstract]   [Full Text] [Related]  

  • 53. Multifocal fixed drug eruption due to celecoxib.
    Bellini V; Stingeni L; Lisi P
    Dermatitis; 2009; 20(3):174-6. PubMed ID: 19470306
    [No Abstract]   [Full Text] [Related]  

  • 54. Daunorubicin-induced hyperpigmentation.
    Pol RR; Wright A; Hill A
    Br J Haematol; 2010 Dec; 151(5):414. PubMed ID: 21029070
    [No Abstract]   [Full Text] [Related]  

  • 55. [A case of ulcerative colitis with sulphasalazine induced megaloblastic anemia].
    Kato Y; Yamamoto M; Yamamoto Y; Yoshida T; Aihara M; Kamishima S; Hasegawa T; Kato Y; Kato R; Koguri T
    Nihon Naika Gakkai Zasshi; 1995 Nov; 84(11):1915-6. PubMed ID: 8568395
    [No Abstract]   [Full Text] [Related]  

  • 56. Fixed drug eruption caused by fulvestrant confirmed by skin tests: First case.
    Broche C; Pralong P; Gil H; Yahiaoui N; Mousseau M; Chatain C; Jacquier JP; Charles J; Leccia MT
    Contact Dermatitis; 2019 Mar; 80(3):184-186. PubMed ID: 30461027
    [No Abstract]   [Full Text] [Related]  

  • 57. Minocycline-induced hyperpigmentation. Treatment with the neodymium:YAG laser.
    Wilde JL; English JC; Finley EM
    Arch Dermatol; 1997 Nov; 133(11):1344-6. PubMed ID: 9371014
    [No Abstract]   [Full Text] [Related]  

  • 58. Bleomycin-Induced Flagellate Hyperpigmentation.
    Wei KY; Wang SH; Ho CL
    J Emerg Med; 2016 Sep; 51(3):e59-60. PubMed ID: 27372378
    [No Abstract]   [Full Text] [Related]  

  • 59. [Exacerbation of ulcerative colitis and the appearance of extraintestinal manifestations after salazopyrine administration].
    Larrañaga JR; Mardomingo P
    Med Clin (Barc); 1984 Feb; 82(6):282-3. PubMed ID: 6142990
    [No Abstract]   [Full Text] [Related]  

  • 60. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
    Andrade P; Gonçalo M
    Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.